Making MUSIC: Collaborative Quality Improvement in Urology
David Miller
University of Michigan Hospital, Ann Arbor, MI, USA Bio
University of Michigan Hospital, Ann Arbor, MI, USA Bio
David Miller currently serves as Chief Clinical Officer for the University of Michigan Hospital and Frankel Cardiovascular Center. Working in partnership with the UH/CVC Executive Director and Chief Nursing Officer, Dr. Miller provides oversight and direction to ensure quality and safety in clinical programs and patient care, improve patient experience, enhance staff engagement, and optimize capacity management within the two hospitals. Dr. Miller is a Professor in the Department of Urology and maintains an active role in providing direct patient care. His clinical practice focuses on the diagnosis and management of patients with prostate and kidney cancer. In addition to his clinical practice, Dr. Miller serves as Director of the Michigan Urological Surgery Improvement Collaborative (MUSIC). Funded by Blue Cross Blue Shield of Michigan (BCBSM), MUSIC is a consortium of more than 40 urology practices aiming to improve the quality and cost‐efficiency of prostate cancer care in the state of Michigan. Dr. Miller also has a broad background in health services research, including substantial experience using claims data and formal training in the advanced statistical methods used in observational data analyses. With longitudinal funding from the Agency for Healthcare Research & Quality and the National Cancer Institute, Dr. Miller's empirical research agenda focuses on comparative effectiveness research, physician‐led collaborative quality improvement, and understanding the relationship between physician organizations, integrated delivery systems, and the quality and cost of specialty care.
Hance Clark
University of Toronto images/logos/hance.jpg
University of Toronto images/logos/hance.jpg
Benjamin Davies
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
A New Era: Machine Learning and Artificial Intelligence in Urology
Larry Goldenberg
University of British Columbia, Vancouver, BC Bio
University of British Columbia, Vancouver, BC Bio
Dr. Goldenberg (CM, OBC, MD, FRCSC, FACS, FCAHS) is a urologic surgeon and clinical scientist with an international reputation for excellence in prostate cancer research and treatment. His current research involves the evaluation of the role of multiparametric MRI in prostate cancer, the potential use of focal therapy, patient education, daVinci robotic prostatectomy and novel treatments for benign prostatic hyperplasia. He has been recognized for his contributions to health care by being inducted into the Order of British Columbia and the Order of Canada.
Management of HGT1 Urothelial Carcinoma - Early Cystectomy Should Still Be Considered
Siamak Daneshmand
University Of Southern California, Los Angeles, CA, USA Bio
University Of Southern California, Los Angeles, CA, USA Bio
Dr. Sia Daneshmand is currently an Associate Professor of Urology with Clinical Scholar designation and serves as director of clinical research as well as the urologic oncology (SUO) fellowship director. His main interests include bladder cancer, advanced kidney cancer and testicular cancer. He has extensive experience in management of complex germ cell tumors and nerve-sparing retroperitoneal lymph node dissection (RPLND) following chemotherapy for advanced testicular cancer. He is one of the highest volume surgeons for this disease in the country. His main research interests focus on the use of pathways to improve peri-operative outcomes following radical cystectomy, use of serum and molecular markers and new technologies in diagnosis and management of bladder and testicular cancers, as well as functional outcomes following orthotopic urinary diversion. He serves on the editorial board of the Journal of Urology, Bladder Cancer Journal, Current Opinions in Urology, the scientific advisory board of Bladder Cancer Advocacy Network (BCAN) as well as the AUA/SUO Guideline Committee on testicular cancer as well as non-muscle invasive bladder cancer. He is a member of Alpha Omega Alpha medical honor society and has been designated one of the “America’s Top Cancer Doctors” for the past 11 consecutive years. He is an active member of the Society of Urologic Oncology, has presented over 400 abstracts at scientific meetings and has authored over 275 peer-reviewed articles, reviews, and book chapters.
This web site is provided as a convenience to you and is for informational purposes only. The information on or available through this web site is not a substitute for professional medical care by a qualified doctor or other health care professional.
CUA Corporate Office
185 Dorval Avenue, Suite 401
Dorval, Quebec H9S 5J9
Tel: +1 514 395 0376
Fax: +1 514 395 1664
This email address is being protected from spambots. You need JavaScript enabled to view it.
185 Dorval Avenue, Suite 401
Dorval, Quebec H9S 5J9
Tel: +1 514 395 0376
Fax: +1 514 395 1664
This email address is being protected from spambots. You need JavaScript enabled to view it.